Urology Specialist Group Llc

CLIA Laboratory Citation Details

1
Total Citation
3
Total Deficiencyies
3
Unique D-Tags
CMS Certification Number 10D2173386
Address 2140 W 68th St Suite 302, Hialeah, FL, 33016
City Hialeah
State FL
Zip Code33016
Phone305 822-7227
Lab DirectorFERNANDO BIANCO

Citation History (1 survey)

Survey - March 10, 2021

Survey Type: Complaint

Survey Event ID: 91PB11

Deficiency Tags: D0000 D5407 D5291

Summary:

Summary Statement of Deficiencies D0000 A complaint survey for 2021001268 was conducted on 3/03/2021-3/10/2021 at Urology Specialist Group LLC. The laboratory was not in compliance with 42 CFR Part 493, Requirements for Laboratories. D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on record review and interview, the laboratory failed to create a general quality assurance (QA) policy for the laboratory regarding Polymerase chain reaction (PCR) testing with Quant studio 3. Findings Included: Review of QuantStudio 3 instrument folder displayed the validation of the instrument was completed on 2/25/2021. Review of QuantStudio 3 manual revealed no documentation of a QA policy onsite. During an interview on 3/9/2021 at 3:11pm, the office manager confirmed there was no QA policy for the PCR testing with QuantStudio 3. D5407 PROCEDURE MANUAL CFR(s): 493.1251(d) Procedures and changes in procedures must be approved, signed, and dated by the current laboratory director before use. This STANDARD is not met as evidenced by: Based on record review and interview, the laboratory failed to have the current Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- laboratory director (LD) sign the procedure manual to approve the use since their hire date on 1/15/2021. Findings Included: A review of CMS-116 revealed LD#B as the current LD. Review of Hiring Emails revealed LD#B started as LD on 1/15/2021. Review of Procedure Manual revealed no documentation of an approval signature by LD#B in the procedure manual. During an interview on 3/9/2021 at 3:11 pm , the office manager confirmed LD#B had not signed the procedure manual for use as of 1 /15/2021. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access